Global Financial Private Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Global Financial Private Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	–	–	396
2020 Q1	$0	Hold	3	–	–	﹤0.01%	392
2019 Q4	$0	Hold	3	–	–	﹤0.01%	402
2019 Q3	$0	Sell	3 -16	-84%	-$2.13K	﹤0.01%	408
2019 Q2	$3K	Buy	+19	New	+$2.62K	﹤0.01%	410
2019 Q1	–	Sell	-2,686	Closed	-$334K	–	372
2018 Q4	$334K	Sell	2,686 -3,753	-58%	-$513K	0.02%	290
2018 Q3	$1.02M	Sell	6,439 -1,169	-15%	-$177K	0.04%	282
2018 Q2	$1.06M	Buy	7,608 +4,367	+135%	+$600K	0.04%	265
2018 Q1	$431K	Buy	+3,241	New	+$442K	0.02%	378

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Global Financial Private Capital's FBT Position: Q2 2020 in Review

Global Financial Private Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 3 shares.

Global Financial Private Capital first reported a position in FBT in Q1 2018 and held it in 8 quarters. The position peaked at $1.06M in Q2 2018. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

Global Financial Private Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
Global Financial Private Capital sold 3 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020.
Global Financial Private Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and held it in 8 quarters.
Global Financial Private Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.06M in Q2 2018.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.